• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Developmental Pharmacology — Drug Disposition, Action, and
Developmental Pharmacology — Drug Disposition, Action, and

... nfants and children are far different from adults in terms of societal, psychosocial, behavioral, and medical perspectives. More than 100 years ago Dr. Abraham Jacobi, the father of American pediatrics, recognized the importance of and need for age-appropriate pharmacotherapy when he wrote, “Pediatr ...
Rx FACTS October 2003
Rx FACTS October 2003

... Approximately 114,000 people in the U.S. are hospitalized each year due to the flu and 3 percent die. For more information regarding influenza, visit the CDC web site at: http://www.cdc.gov/nip/Flu and the September 2003 issue of Rx Facts. Serious Health Risks Created by Importation of Unapproved Dr ...
5-Antifungal Chemotherapy
5-Antifungal Chemotherapy

... Exploring Mech. of Resistance from Mech. of Actions • A gene coding an enzyme that synthesizes a particular fungal cell wall polysaccharide is mutated. A fungal pathogen might, in this way, develop resistance to which of the following agents? • A fungal pathogen has been found accumulating low ergo ...
Tuberculosis: New Drug Discovery Pipelines
Tuberculosis: New Drug Discovery Pipelines

... new classes of anti-TB drugs [20]. Drug resistance in tuberculosis [21-23] TB organisms resistant to the drugs used in its treatment are widespread and occur in all countries. Drug resistance emerges as a result of inadequate treatment and once TB organisms acquire resistance they can spread from pe ...
The role of the liver in drug metabolism
The role of the liver in drug metabolism

... HEPATIC METABOLISM The smooth endoplasmic reticulum of the hepatocyte is the principal site of metabolism in the liver, with the enzymes being contained within the microsomes. The largest family of membrane-bound, nonspecific, mixed-function enzymes is called the cytochrome P450 system. It contains ...
The Nursing Process and Drug Therapy
The Nursing Process and Drug Therapy

... effects a medication predictably will cause • May be harmless or serious • If side effects are serious enough to negate the beneficial effect of meds therapeutic action, it may be D/C’d • People may stop taking medications because of the ...
Autonomic Nervous System Anticholinergic Drugs
Autonomic Nervous System Anticholinergic Drugs

... its persistence in the body is increased by : 1- Neostigmine, which inactivate that enzyme. 2- In patient with hepatic disease or severe malnutrition, whose plasma concentration of enzyme may be lower than normal. 3- Procaine also is destroyed by this enzyme and so by competing with suxamethonium fo ...
FDA`s Acetaminophen Notice: A Snapshot of the Current Regulatory
FDA`s Acetaminophen Notice: A Snapshot of the Current Regulatory

... as opposed to six days in 2009.12 FDA’s Center for Drug Evaluation and Research convened 51 days of Advisory Committee meetings per year in 2009 and 2010, approximately double the number of meeting days held per year from 2006 to 2008.13 In summary, FDA’s actions of January 2011 will not only affect ...
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)

... patients.6 Higher drug demands by elder people has lead to increased coverage of outpatient prescriptions by third-party insurance, continues introduction of new drugs to manage chronic diseases and changes over of medications from prescription to non-prescription status.7Inter-individual variabilit ...
2-Ocular pharmacology and toxicology
2-Ocular pharmacology and toxicology

... • Acute, painful increases of pressure due to occlusion of the outflow drainage pathway • emergency situation that require treatment before surgery (Iridectomy) The use of drugs is limited to : • Oral Acetazolamide • Topical cholinomimetics e.g.: pilocarpine • Osmotic agents: hypertonic solution( Ma ...


... Clinical form of TB resistant to rifampicin and to isoniazid was conceptually called multidrug-resistant tuberculosis in the United States in the end of the 1980’s. Between 1982 and 1986, there was an expressive increase in the multiresistant forms, leading to recognition of the problem as a public ...
Thai FDA - cri.or.th
Thai FDA - cri.or.th

... Acquired Immune Deficiency Syndromes (AIDS) is an important disease in this century. Many scientists are searching for a way to cure this disease, but until today a treatment for AIDS has not been discovered. Drug Companies continue to look for a drug that can be used to cure this disease already th ...
Options for regulating new psychoactive drugs: a review of
Options for regulating new psychoactive drugs: a review of

... describe such substances. These include legal highs, synthetics, research chemicals, designer drugs and party drugs, all of which are within the scope of this review. The problem is not an entirely new one. Late 20th century chemistry was advanced enough to produce a rapid flow of new psychoactive d ...
Dr. Reddy Qs - Website of Neelay Gandhi
Dr. Reddy Qs - Website of Neelay Gandhi

... All statements about clindamycin are true except: a) it is effective against anaerobic infections like B.fragilis b) mechanism of action is similar to erythromycin. c) it has very less CNS penetration d) it is effective in the treatment of acne. e) Bone marrow stimulation can be seen with this drug ...
PLAIN SIGHT in
PLAIN SIGHT in

... consumption of health care, and new federal regulations that required a prescription for the sale of ethical pharmaceuticals. As brand-name drugs became increasingly important to physicians’ practices and to pharmaceutical company profits, competition between firms heightened.17 The resultant increa ...
Chapter 16 Cholinesterase Inhibitors
Chapter 16 Cholinesterase Inhibitors

... Migraine headache I: characteristics and overview of treatment Migraine headache II: abortive therapy Migraine headache III: preventive therapy Cluster headaches Tension-type headache ...
Increase of drug tolerance An alternative to acid dissociation
Increase of drug tolerance An alternative to acid dissociation

... ●  Dilution effect for matrix interference vs. specific analyte may not go parallel (although the desired effect is to dilute interference faster than specific signal) ...
Club Drugs and HIV Infection: A Review
Club Drugs and HIV Infection: A Review

... (MDMA; also known as “Ecstasy”), methamphetamine, ketamine, g-hydroxybutyrate (GHB), and inhaled nitrites (known as “poppers”). The present article provides a general overview of the epidemiological profile and medical consequences of club drugs and also provides recommendations for clinicians treat ...
acebutolol-drug-doc - Prime Academic Writers
acebutolol-drug-doc - Prime Academic Writers

... administering the medicine. The patient may experience Diarrhea is due to the different reaction-participating in the body. A patient may experience uneven heartbeats mostly in the case where the patient has some other condition. The patient may experience the chest pain due to being short of the br ...
FY M.Pharm Medicinal Natural Products
FY M.Pharm Medicinal Natural Products

... Microbial Toxins – Ciejler, Kadis and Ajl- Academic Press Antimicrobial in food- Alfred Larry Branen, P. Michael Davidson. Publishing Corporation ...
Clinical Research And Treatment
Clinical Research And Treatment

... subjects to continue to receive the benefits of the investigational drug, agent, or biologic until marketing approval is obtained. ...
View PPT - Indian Drug Manufacturers` Association
View PPT - Indian Drug Manufacturers` Association

... In that year South Africa allowed generic production of ARVs for treating HIV patients, despite the fact they were covered by patents and 40 MNCs bought litigation against South Africa for its act. ...
Slide 1
Slide 1

... An investigator shall administer the drug only to subjects under the investigator's personal supervision or under the supervision of a subinvestigator responsible to the investigator. The investigator shall not supply the investigational drug to any person not authorized to receive it. Sec. 312.60 G ...
EXCRETION OF DRUGS
EXCRETION OF DRUGS

... Export into the intestinal lumen by P-gp cause low bioavailability of the P-gp-substrate drugs when given orally, and may contribute to their elimination when given parenterally. - Substrates of MRP-2 (organic acids; significance still requires definition) 2. By diffusion: extremely lipophilic compo ...
Phychiatric Drugs. Central Nervous System
Phychiatric Drugs. Central Nervous System

... • Caffeine is completely absorbed by the stomach and small intestine within 45 minutes of ingestion. After ingestion it is distributed throughout all tissues of the body and is eliminated by first-order kinetics. The half-life of caffeine varies widely among individuals according to such factors as ...
< 1 ... 60 61 62 63 64 65 66 67 68 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report